Skip to main content
European Commission logo
français français
CORDIS - Résultats de la recherche de l’UE
CORDIS
CORDIS Web 30th anniversary CORDIS Web 30th anniversary

European Glaucoma Research Training program - Advancing the Approach of Advanced glaucoma

Description du projet

Un programme de formation sur les thérapies du glaucome

Le glaucome est une maladie oculaire associée à une lésion du nerf optique qui relie l’œil au cerveau. S’il n’est pas traité rapidement, le glaucome se développe et peut entraîner une perte de la vision. La mission du projet EGRET-AAA, financé par le programme Actions Marie Skłodowska-Curie, est de mettre au point des traitements innovants du glaucome. Le consortium propose un programme de doctorat conjoint à l’intention des chercheurs en début de carrière, qui leur permet d’étudier la thérapie génique et les approches fondées sur les cellules souches pour traiter le glaucome à l’aide de la technologie des organoïdes. Les conclusions de l’étude d’EGRET-AAA amélioreront la qualité de vie de millions de personnes souffrant de cette maladie dans le monde et réduiront le fardeau socio-économique que celle-ci fait peser.

Objectif

EGRET-AAA is a joint doctorate program to provide training in glaucoma research, leading to joint doctoral degrees for 15 ESRs. It converts existing partnerships between universities into long-lasting ones. Together with many private and societal partners, our consortium forms a cradle for a European network of highly skilled, resilient, entrepreneurial and creative researchers, who will inspire each other to excel in glaucoma research, both during and long after the funding period.

EGRET-AAA will produce innovative treatments to protect and restore vision in patients with progressive eye disease glaucoma. By using revolutionary human retinal organoids, we will accelerate the development of new treatments and bring gene therapy and stem cell-based approaches a major step closer to clinical implementation, while minimizing the need for animal research. Through our findings, we will be able to protect the regenerated eye-brain connections and develop diagnostic techniques to select patients suitable for treatment and to evaluate intervention effects. By doing so, we will ultimately save approximately 1 million Europeans from blindness, and another 5 million from significant vision loss, thereby increasing their quality of life, and dramatically reducing societal and health care costs.

Through our interdisciplinary and inter-sectoral training, the 15 ESRs will gain essential skills and assets for success in a broad range of careers in academia and beyond. Based on our previous experience gained on multiple training networks, we believe that this timely program provides an in-depth graduate research training environment of unrivalled quality and pertinence, far greater and better than the sum of its parts. By anticipating continued demand for the skills and experience of our ESRs, we see EGRET-AAA as the precursor of a permanent and sustainable glaucoma-focused European doctoral program.

Coordinateur

ACADEMISCH ZIEKENHUIS GRONINGEN
Contribution nette de l'UE
€ 1 097 481,60
Adresse
HANZEPLEIN 1
9713 GZ Groningen
Pays-Bas

Voir sur la carte

Région
Noord-Nederland Groningen Overig Groningen
Type d’activité
Higher or Secondary Education Establishments
Liens
Coût total
Aucune donnée

Participants (6)

Partenaires (19)